DEA Schedule CIII
Strength
50 mg/1
Manufacturer
KVK-Tech Inc.NDC
10702004003
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
BENZPHETAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090968On Market Since
7/21/2010
Pharmacological Classes
Related Drugs
Same classification
NASAL SPRAY 0.05%
Generic
36800030410•Topco Associates LLC
$0.0625
per ML
NASAL SPRAY 0.05%
Generic
36800081710•Topco Associates LLC
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203005•Taro Pharmaceuticals U.S.A. Inc.
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203003•Taro Pharmaceuticals U.S.A. Inc.
$0.0678
per ML
PHENTERMINE 37.5 MG TABLET
Generic
10702002501•KVK-Tech Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
10702002510•KVK-Tech Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
11534016001•Sunrise Pharmaceutical Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
11534016003•Sunrise Pharmaceutical Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
11534016030•Sunrise Pharmaceutical Inc.
$0.0694
per EA
PHENTERMINE 37.5 MG TABLET
Generic
43547040410•Solco Healthcare US LLC
$0.0694
per EA